J&J’s Marketer E-Mailed Hip Safety Concerns Before Recall

A top marketing executive at Johnson & Johnson’s DePuy unit said the company should consider a recall of a hip implant almost a year before 93,000 of the devices were recalled, according to an internal e-mail shown to jurors.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.